Neal C. Bradsher, 10% Owner at OncoCyte Corp (OCX), bought 2,782,932 shares at $2.16 ($6.0M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.16 | 623,090 | $1.3M | 22.4% |
| 2 | $2.16 | 623,090 | $1.3M | 22.4% |
| 3 | $2.16 | 768,376 | $1.7M | 27.6% |
| 4 | $2.16 | 768,376 | $1.7M | 27.6% |
| Total | $2.16 avg | 2,782,932 | $6.0M | 100% |
| Filing → |
| STAA | BUY | 2026-01-08 | $8.8M | — | Filing → |
| STAA | BUY | 2025-11-21 | $82.1M | — | Filing → |
| STAA | BUY | 2025-04-10 | $5.4M | — | Filing → |